Is this you? Create Your Porfile
Avatar

Xiaojie Zhou

Procter & Gamble

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Xiaojie Zhou is active.

Explore More

Publication

Featured researches published by Xiaojie Zhou.

Journal of the American Geriatrics Society | 2010

Assessment of the Relationship Between Age and the Effect of Risedronate Treatment in Women with Postmenopausal Osteoporosis: A Pooled Analysis of Four Studies

Steven Boonen; Andrea B. Klemes; Xiaojie Zhou; Robert Lindsay

OBJECTIVES: To quantify the effect of age on the incidence of osteoporosis‐related fractures and of risedronate treatment on fracture risk in different age groups in women with postmenopausal osteoporosis.

Bone | 2006

Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: Sequential triple biopsy studies with micro-computed tomography

Babul Borah; T.E. Dufresne; Erik L. Ritman; Steven M. Jorgensen; S. Liu; Paula A. Chmielewski; Roger Phipps; Xiaojie Zhou; Jean Sibonga; Russell T. Turner

Osteoporosis International | 2012

Vertebral fracture efficacy during risedronate therapy in patients using proton pump inhibitors

C. Roux; J. L. Goldstein; Xiaojie Zhou; A. Klemes; Robert Lindsay

Bone | 2009

The risk of osteoporosis-related fracture in diabetic patients

Robert Lindsay; Xiaojie Zhou; A. Klemes

Archive | 2008

Poster Number 174 Prevention and Treatment of Osteoporosis

Robert Lindsay; Jay L. Goldstein; Xiaojie Zhou; Gamble Pharmaceuticals; Andreas Gruauer

Journal of Clinical Densitometry | 2008

Risedronate Did Not Increase Gastrointestinal Adverse Events(AES) In Subjects Taking Nonsteroidal Anti-Inflammatory Drugs (NSAIDS) Or Aspirin

Robert Lindsay; Jay L. Goldstein; Xiaojie Zhou; Christian Roux; Andreas Gruauer

Journal of Clinical Densitometry | 2008

Risedronate Shows Consistent Reduction of The Risk of New Vertebral Fractures Over Three Years In Proton Pump Inhibitor (PPI) and H2-Receptor Antagonist (H2RA) Users

Robert Lindsay; Jay L. Goldstein; Xiaojie Zhou; Christian Roux

Bone | 2008

Comparison of bone architecture via micro-ct after long-term treatment with risedronate and alendronate: A cross-sectional study in women with postmenopausal osteoporosis

T.E. Dufresne; Paula A. Chmielewski; Joe Nurre; Babul Borah; Xiaojie Zhou; Roger Phipps; G. Woodson; P.D. Miller

Bone | 2008

Vertebral fracture efficacy with risedronate is apparent early and is sustained

Nelson B. Watts; Christian Roux; Xiaojie Zhou; Andreas Grauer

Bone | 2008

Early and sustained non-vertebral fracture efficacy with risedronate

Robert Lindsay; Christian Roux; Jonathan D. Adachi; Xiaojie Zhou; Andreas Grauer; Nelson B. Watts

Explore More

Collaboration

Dive into the Xiaojie Zhou's collaboration.

Top Co-Authors
Avatar

Robert Lindsay

Columbia University

View shared research outputs
Top Co-Authors
Avatar

A. Klemes

Procter

View shared research outputs
Top Co-Authors
Avatar

Andreas Grauer

Procter

View shared research outputs
Top Co-Authors
Avatar

Babul Borah

Procter

View shared research outputs
Top Co-Authors
Avatar

Nelson B. Watts

University of Cincinnati

View shared research outputs
Top Co-Authors
Avatar

Paula A. Chmielewski

Procter

View shared research outputs
Top Co-Authors
Avatar

Roger Phipps

Husson University

View shared research outputs
Top Co-Authors
Avatar

T.E. Dufresne

Procter

View shared research outputs
Top Co-Authors
Avatar

Erik L. Ritman

Mayo Clinic

View shared research outputs
Top Co-Authors
Avatar

J. L. Goldstein

University of Illinois at Chicago

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge